Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. indications: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - salbutamol sulfate -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - salbutamol sulfate -

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. indications: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

remedica ltd. - salbutamol (salbutamol sulfate) - tablets - 4mg (100/10x10/) in blister

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

arpimed llc - salbutamol (salbutamol sulfate) - tablets - 2mg

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation - inhalation, pressurised - excipient ingredients: norflurane - indicated for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation - inhalation, pressurised - excipient ingredients: norflurane - indicated for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - salbutamol sulfate 120ug equivalent to salbutamol 100 µg;   - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol sulfate 120ug equivalent to salbutamol 100 µg   excipient: ethanol norflurane oleic acid - with its fast onset of action, it is particularly suitable for the management and prevention of attack in mild asthma and for the treatment of acute exacerbations in moderate and severe asthma.